Concourse Financial Group Securities, Inc. Lixte Biotechnology Holdings, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.51 - $1.89 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.48 - $6.0 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.12 - $5.9 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.12 - $0.35 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.16 - $0.35 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$0.21 - $0.57 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$0.52 - $0.85 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$0.46 - $0.89 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$0.8 - $1.2 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$0.72 - $58.7 $0 - $0
0 New
0 $0

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email